DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients – Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group

Publication | Closed Access

DOI

113

Citations

References

2007

Year

Sabine Maier, Inko Nimmrich, Thomas Koenig, Serenella Eppenberger‐Castori, Inga Bohlmann, Angelo Paradiso, Frédérique Spyratos, Christoph Thomssen, Volkmar Mueller, Jörg Nährig,

European Journal of Cancer

Tumor BiologyBreast OncologyCancer RiskMedicinePathobiology GroupPathologyCancer GenomicsBreast CancerMolecular OncologyClinical ValidationCancer GeneticsDistant Disease RecurrenceOncologyRadiation OncologyCancer Research